General Information of the Compound
Compound ID
CP0560049
Compound Name
1-[4-[5-(4-chlorophenyl)-1,3-benzoxazol-2-yl]butyl]-3-pyridin-4-ylimidazolidin-2-one
    Show/Hide
Structure
Formula
C25H23ClN4O2
Molecular Weight
446.938
Canonical SMILES
Clc1ccc(cc1)-c1ccc2oc(CCCCN3CCN(C3=O)c3ccncc3)nc2c1
    Show/Hide
InChI
InChI=1S/C25H23ClN4O2/c26-20-7-4-18(5-8-20)19-6-9-23-22(17-19)28-24(32-23)3-1-2-14-29-15-16-30(25(29)31)21-10-12-27-13-11-21/h4-13,17H,1-3,14-16H2
    Show/Hide
InChIKey
WDRGAUGICGXAOS-UHFFFAOYSA-N
Physicochemical Property
logP
5.8081
Rotatable Bonds
7
Heavy Atom Count
32
Polar Areas
62.47
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145973872
ChEMBL ID
CHEMBL4214259
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06427, Genome polyprotein
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000264 RD Homo sapiens (Human)  1
1
EC50 = 1100 nM
   TI
   LI
   LO
   TS